Alphatec Holdings, Inc. (ATEC) Bundle
A Brief History of Alphatec Holdings, Inc. (ATEC)
Company Overview
Alphatec Holdings, Inc. is a medical device company focused on spine surgery technologies. Headquartered in Carlsbad, California, the company trades on NASDAQ under the ticker ATEC.
Financial Performance
| Financial Metric | 2023 Value |
|---|---|
| Total Revenue | $294.3 million |
| Net Income | -$56.2 million |
| Gross Margin | 65.4% |
| Cash and Equivalents | $124.7 million |
Product Portfolio
- ALIF (Anterior Lumbar Interbody Fusion) systems
- Posterior fixation technologies
- Minimally invasive surgical solutions
Market Position
Market Capitalization: $785.6 million as of January 2024
Research and Development
R&D Expenditure in 2023: $45.6 million
Operational Metrics
| Metric | 2023 Data |
|---|---|
| Total Employees | 644 |
| Number of Patents | 127 |
| International Market Presence | 18 countries |
A Who Owns Alphatec Holdings, Inc. (ATEC)
Major Institutional Shareholders
| Shareholder | Shares Owned | Percentage |
|---|---|---|
| BlackRock Inc. | 5,743,360 | 9.86% |
| Vanguard Group Inc. | 4,623,202 | 7.93% |
| Perceptive Advisors LLC | 3,912,500 | 6.71% |
Insider Ownership
- Patrick S. Parker (President & CEO): 1,245,678 shares
- Jeff Black (CFO): 356,789 shares
- Other Executive Officers: 876,543 shares
Ownership Structure
Public Float: 58,234,567 shares
Total Outstanding Shares: 62,345,678 shares
Top Institutional Investors
| Investor | Total Value | Quarter |
|---|---|---|
| Millennium Management LLC | $42,567,890 | Q4 2023 |
| Point72 Asset Management | $35,678,901 | Q4 2023 |
| Goldman Sachs Group Inc. | $28,765,432 | Q4 2023 |
Alphatec Holdings, Inc. (ATEC) Mission Statement
Corporate Overview
Alphatec Holdings, Inc. is a medical device company focused on surgical solutions for spine and orthopedic procedures. As of 2024, the company's market capitalization is $449.38 million.
Mission Statement Components
| Focus Area | Key Details |
|---|---|
| Primary Business | Spine and orthopedic surgical technologies |
| Annual Revenue (2023) | $291.6 million |
| R&D Investment | $53.4 million |
Strategic Objectives
- Develop innovative surgical technologies
- Improve patient outcomes
- Enhance surgical precision
Key Performance Metrics
| Metric | 2023 Value |
|---|---|
| Gross Margin | 65.2% |
| Net Income | -$42.1 million |
| Product Portfolio | Over 100 surgical solutions |
Technological Focus
Core technological areas include:
- Minimally invasive surgical systems
- Advanced spinal implant technologies
- Robotic-assisted surgical platforms
Market Positioning
Alphatec holds approximately 3.5% of the global spine surgery market, with strategic expansion plans targeting emerging medical technology segments.
How Alphatec Holdings, Inc. (ATEC) Works
Company Overview
Alphatec Holdings, Inc. is a medical device company focused on spine surgery technologies. Headquartered in Carlsbad, California, the company develops and manufactures surgical solutions for spine-related medical procedures.
Financial Performance
| Financial Metric | 2023 Value |
|---|---|
| Total Revenue | $579.1 million |
| Gross Profit | $311.4 million |
| Net Loss | $77.5 million |
| Cash and Equivalents | $198.6 million |
Product Portfolio
- ALIF (Anterior Lumbar Interbody Fusion) systems
- Posterior fixation technologies
- Minimally invasive surgical solutions
- Interbody fusion devices
Market Segments
Primary Markets:
- United States spine surgery market
- International orthopedic medical device markets
Research and Development
R&D Expenditure in 2023: $97.3 million
Operational Metrics
| Metric | 2023 Data |
|---|---|
| Number of Employees | 734 |
| Manufacturing Facilities | 2 locations |
| FDA Approved Devices | 23 surgical technologies |
Stock Performance
NASDAQ Ticker: ATEC
| Stock Metric | Current Value |
|---|---|
| Share Price (January 2024) | $7.85 |
| Market Capitalization | $825.6 million |
How Alphatec Holdings, Inc. (ATEC) Makes Money
Revenue Streams
Alphatec Holdings, Inc. generates revenue through the following primary channels:
- Spinal implant and surgical technology sales
- Medical device product portfolio
- Surgical instrument and solution offerings
Financial Performance
| Financial Metric | 2023 Value |
|---|---|
| Total Revenue | $577.4 million |
| Gross Profit | $348.9 million |
| Net Income | $-53.7 million |
Product Portfolio
Surgical Technology Categories:
- Posterior fixation systems
- Interbody fusion devices
- Cervical spine solutions
- Minimally invasive surgical technologies
Market Segments
| Market Segment | Revenue Contribution |
|---|---|
| US Spine Market | 89% of total revenue |
| International Markets | 11% of total revenue |
Sales Channels
- Direct sales force
- Distributor networks
- Hospital procurement channels
- Orthopedic surgeon partnerships
Alphatec Holdings, Inc. (ATEC) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.